RxDoctor Payments DataLook up a doctor →

Saad Ahmad, MD

Advanced Heart Failure and Transplant Cardiology · Morristown, NJNPI 1811150816

Payments from drug & device makers

$367,514in general payments, 2019–2025

Across 544 payments — averaging $675.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • CSL Behring$82K
  • Boehringer Ingelheim International GmbH$55K
  • Procyrion, Inc.$52K
  • Boehringer Ingelheim Pharma GmbH & Co.kg$33K
  • Inari Medical, Inc.$32K
  • Abbott$32K
  • plus $83K from 47 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
CSL Behring51$81,587
Boehringer Ingelheim International GmbH5$54,563
Procyrion, Inc.2$51,942
Boehringer Ingelheim Pharma GmbH & Co.kg3$32,530
Inari Medical, Inc.30$32,182
Abbott123$31,850
Pfizer40$26,677
Amgen14$16,199
Shockwave Medical, Inc19$10,522
Bayer19$7,725
Abiomed39$6,404
Boston Scientific51$5,563
Angiodynamics, Inc.8$2,545
AOP Health US, LLC1$797
Stryker5$710
Imperative Care, Inc9$605
AstraZeneca6$561
EKOS Corporation3$516
Livanova USA, Inc.5$499
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)15$381
Impulse Dynamics (USA) Inc.4$335
Teleflex LLC5$330
Alnylam Pharmaceuticals Inc.10$287
Reflow Medical Inc3$276
Merck12$201
Philips North America LLC2$178
Boehringer Ingelheim8$142
Johnson & Johnson3$133
Actelion Pharmaceuticals US, Inc.8$133
Gilead1$125
Truvic Medical, Inc.4$98
Novo Nordisk3$97
Penumbra, Inc.1$81
Endotronix, Inc.2$78
Novartis4$69
Medtronic2$68
Cardiva Medical, Inc.2$67
United Therapeutics Corporation3$57
Lexicon Pharmaceuticals, Inc.3$57
Baxter Healthcare1$50
Argon Medical Devices, Inc.2$46
Bridgebio Pharma, Inc.2$38
Verona Pharma, Inc.1$26
Cardiovascular Systems Inc.1$25
Cvrx, Inc.1$25
Scpharmaceuticals Inc.1$20
Astellas Pharma US Inc1$19
Getinge USA Sales, LLC1$18
E.r. Squibb & Sons, L.L.C.1$17
Kiniksa Pharmaceuticals International, PLC1$16
Amarin Pharma, Inc.1$16
Kestra Medical Technology Services, Inc.1$15
AbbVie1$13

How this compares

$367,514 in reported general payments places this provider in the 95th percentile of 21 advanced heart failure and transplant cardiology providers in New Jersey.

See all advanced heart failure and transplant cardiology providers in New Jersey →

Medicare billing

Part B allowed, 2024
$68,243
Medicare patients
153
Services billed
422

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other advanced heart failure and transplant cardiology in Morristown

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →